Vcanbio Cell & Gene Engineering Corp., Ltd Stock
Equities
600645
CNE000000545
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.8 CNY | +4.89% | +13.81% | -12.19% |
Sales 2022 | 1.55B 215M | Sales 2023 | 1.59B 220M | Capitalization | 9.49B 1.31B |
---|---|---|---|---|---|
Net income 2022 | 113M 15.61M | Net income 2023 | 106M 14.64M | EV / Sales 2022 | 4.31 x |
Net cash position 2022 | 1.25B 173M | Net cash position 2023 | 1.47B 202M | EV / Sales 2023 | 5.04 x |
P/E ratio 2022 |
70.9
x | P/E ratio 2023 |
88.1
x | Employees | 2,332 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 71.64% |
1 day | +4.89% | ||
1 week | +13.81% | ||
Current month | +8.54% | ||
1 month | +8.54% | ||
3 months | +4.71% | ||
6 months | -5.27% | ||
Current year | -12.19% |
Managers | Title | Age | Since |
---|---|---|---|
Yong Wang
CEO | Chief Executive Officer | 57 | 09-06-29 |
Xiao Ting Wang
DFI | Director of Finance/CFO | 42 | 22-05-24 |
Hai Bin Li
BRD | Director/Board Member | 53 | 16-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Jia Gong
CHM | Chairman | 59 | 22-03-25 |
Yan Wang
CHM | Chairman | 53 | 23-05-15 |
Hong Qi Wang
BRD | Director/Board Member | 59 | 23-05-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +1.32% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 17.8 | +4.89% | 14,577,400 |
24-04-29 | 16.97 | +3.16% | 6,362,100 |
24-04-26 | 16.45 | +0.73% | 4,613,369 |
24-04-25 | 16.33 | +1.24% | 4,311,099 |
24-04-24 | 16.13 | +1.38% | 3,420,213 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-12.19% | 1.15B | |
-0.60% | 12.63B | |
-9.59% | 7.67B | |
+1.82% | 5.42B | |
+0.02% | 4.57B | |
-51.89% | 3.51B | |
+6.42% | 2.59B | |
-14.59% | 2.05B | |
-8.29% | 1.79B | |
+1.67% | 1.77B |
- Stock Market
- Equities
- 600645 Stock